Navigation Links

Biology Technology

Report: Radical New IVD Test Approaches Key To Growth

10/22/2014
NEW YORK , Oct. 22, 2014 New test innovations will be the source of revenue growth in the in vitro diagnostic (IVD) test industry, especially as companies struggle with reimbursement challenges, according to Kalorama Information. The healthcare market researcher listed more than 25 testing innovations in important disease areas in academic settings that could be the futur... [Comments]

Global DNA Diagnostics Market (Product types, Application, Technology, End User and Geography) - Forecast to 2020

10/22/2014
DUBLIN , Oct. 22, 2014 Research and Markets has announced the addition of the "Global DNA Diagnostics Market (Product types, Application, Technology, End User and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020" report to their offering. This new report titled,... [Comments]

Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin

10/22/2014
DUBLIN and BOSTON , Oct. 22, 2014  Actavis plc (NYSE: ACT ), a leading global specialty pharmaceutical company, and Rhythm, a biopharmaceutical company, today announced that Actavis has been granted an exclusive option to acquire Rhythm's wholly owned subsidiary, Rhythm Health, Inc., which is developing relamorelin (RM-131), a peptide ghrelin agonist, for the treatme... [Comments]

The Americas Inorganic Refrigerants Market is estimated to grow to $71.6 million by 2018 - New Report by MicroMarket Monitor

10/22/2014
(PRWEB) October 21, 2014 The Americas Inorganic Refrigerants Market report defines and segments the inorganic refrigerants market in Americas with analysis and forecast of revenue. Browse through the TOC of the Americas Inorganic Refrigerants Market report, to get an idea of the in-depth analysis provided. This also provides a glimpse of the segmentation in the Americas inorganic refrige... [Comments]

The North American crystal oscillator market is expected to reach $623.6 million by 2018 - New Report by MicroMarket Monitor

10/22/2014
(PRWEB) October 21, 2014 The North American crystal oscillator market report defines and segments the concerned market North America with analysis and forecast of revenue. This market was valued at $531.4 million in 2013, and is expected to reach $623.6 million by 2018, at a CAGR of 3.3% from 2013 to 2018. Browse through the TOC of the North American crystal oscillator market report, to... [Comments]

Shimadzu Releases QuantAnalytics Open Access LCMS Software Package for Clinical Applications

10/22/2014
Columbia, Md. (PRWEB) October 21, 2014 Shimadzu Scientific Instruments introduces its Open Solution QuantAnalytics(TM) software package, an LC/MS/MS data tool for the pain management and clinical markets. The software increases the speed and efficiency of data processing and review by allowing users to highlight and review results that are of specific importance to clinicians. QuantAnal... [Comments]

Involution Studios' Ebola Infographic Provides Key Disease Information and Statistics at a Glance

10/22/2014
Arlington, Massachusetts (PRWEB) October 22, 2014 Involution Studios , a healthcare software design company, recently announced the release of a new infographic, Understanding Ebola . The goal of the project was to create a beautifully designed, easy to follow informative tool for anyone wanting to know more about Ebola's transmission, areas of outbreak, symptoms and prevention. &... [Comments]

myPROpad™ Topic of Panel Discussion at the Yale Food Systems Symposium

10/22/2014
Cranford, NJ (PRWEB) October 22, 2014 WriteResult, LLC – a premier provider of ePRO technologies and services – has been working with a team of researchers from Yale University’s School of Public Health and New Haven Farms Community Farming Collaborative to provide electronic questionnaire data collection through use of their iPad-based ePRO solution. The study, which started in May, aims... [Comments]

Pipette.com Launches the Addition of Sartorius CPA Semi-Micro Balance to Their Product Portfolio with Special Promotional Pricing

10/22/2014
San Diego, CA (PRWEB) October 22, 2014 Currently offering a comprehensive portfolio of laboratory balances from Sartorius, A & D Weighing, Rice Lake, and Ohaus, Pipette.com has added the Sartorius CPA Semi-Micro Balance . The Sartorius CPA Semi-Micro Balance is ideal for lab technicians looking for an affordable high-quality, precise, and user-friendly laboratory balance. Sartorius... [Comments]

Dr. Yousef Siddiqui joins the Grace Century Advisory Team

10/22/2014
Ras Al Khaimah, UAE (PRWEB) October 22, 2014 Grace Century, a private equity consultancy specializing in game-changing life science and healthcare projects, announces the addition of Dr. Yousef “Josh” Siddiqui , BSc MBBS MRCGP DRCOG DCH to its advisory team. Dr. Siddiqui will provide further healthcare expertise to its international research advisory team. A graduate of University Col... [Comments]

PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu

10/22/2014
Rock Hill, SC (PRWEB) October 22, 2014 Physicians Choice Laboratory Services (PCLS) announces the expansion of its cardiovascular pharmacogenetics menu, which enables healthcare providers to individualize therapeutic treatments for improved patient outcomes. With PCLS’s evidence-based results, healthcare providers are better able to assess patients’ individual needs and optimize their ther... [Comments]

Medicine Technology

Medical Diagnostic Laboratories, L.L.C. Institute for Biomarker Research Announces New Prenatal Cystic Fibrosis Tests

10/22/2014
HAMILTON, N.J. , Oct. 22, 2014  Medical Diagnostic Laboratories, L.L.C., (MDL), a CLIA-certified, CAP-accredited laboratory which specializes in high complexity, state-of-the-art, automated DNA-based molecular analyses, announces that it is now offering new Cystic Fibrosis Testing which utilizes cutting edge technology, including next- generation DNA sequencing platforms.... [Comments]

Cephasonics Launches the cQUB-1, First Product in New Family of cQUB White-Label Ultrasound Systems Targeted at Medical Applications

10/22/2014
SANTA CLARA, Calif. , Oct. 22, 2014  Cephasonics, a technology-innovation leader with a game-changing embedded-ultrasound platform, today announced the introduction of the cQUB™-1 (cQuest Ultrasound Box™-1), the first product in a new family of cQUB white-label ultrasound systems designed and manufactured by Cephasonics for purchase by companies to rebrand with... [Comments]

Hydrocodone: Rescheduled, Repositioned & Reinvented

10/22/2014
FAIRFIELD, N.J. , Oct. 22, 2014  Rescheduling of hydrocodone combination products (HCPs) will impel a major transformation in the pain market, according to a new primary market research study by Pain Insights, Inc., a firm providing market research and consultation exclusively in the area of pain management. Photo - http://photos.prnewswire.com/prnh/20141021/153440... [Comments]

Quest Diagnostics Adds Jeffrey M. Leiden, M.D., Ph.D., to Board of Directors

10/22/2014
MADISON, N.J. , Oct. 22, 2014  Quest Diagnostics (NYSE: DGX ), the world's leading provider of diagnostic information services, today announced that its Board of Directors has elected Jeffrey M. Leiden, M.D., Ph.D., to serve as a director, effective December 1, 2014. Including Dr. Leiden, the Board has 11 members. Dr. Leiden is the Chairman, President and CEO of V... [Comments]

Market Momentum on Biotech Stocks - Amicus Therapeutics, Progenics Pharma, Threshold Pharma, Idera Pharma, and Merrimack Pharma

10/22/2014
LONDON , October 22, 2014 Investor-Edge has initiated coverage on the following equities: Amicus Therapeutics Inc. (NASDAQ: FOLD ), Progenics Pharmaceuticals Inc. (NASDAQ: PGNX ), Threshold Pharmaceuticals Inc. (NASDAQ: THLD ), Idera Pharmaceuticals Inc. (NASDAQ: IDRA ), and Merrimack Pharmaceuticals Inc. (NASDAQ: MACK). Free research on these five companies can be a... [Comments]

Biomarker Discovery Company, Antigen Discovery Inc., Awarded an NIH Phase I Small Business Innovation Research Grant to Develop a Pan-HIV Protein Microarray Chip

10/22/2014
IRVINE, Calif. , Oct 22, 2014 Antigen Discovery Inc. (ADi), a privately held company in Irvine, California , announced the receipt of a National Institutes of Health (NIH) Phase I Small Business Innovation Research award (SBIR) from the National Institute of Dental and Craniofacial Research (NIDCR). The one-year $225,000 award will fund the development of a Pan-HI... [Comments]

PCCA Awards Charlene Vernak, RPh, the George Roentsch Scholarship

10/22/2014
HOUSTON , Oct. 22, 2014  Charlene Vernak, RPh, of Vernak Farms Pharmacy in Skaneateles, New York , recently was awarded the George Roentsch Scholarship by the Professional Compounding Centers of America (PCCA). Vernak received the award in Houston during PCCA's International Seminar, held October 8-10, 2014. The scholarship is awarded annually to an... [Comments]

New IVF Research Highlights Improved Genetic Screening Approach To Help Parents Have Healthier Babies

10/22/2014
BASKING RIDGE, N.J. , Oct. 22, 2014   Reproductive Medicine Associates of New Jersey (RMANJ), a world-renowned leader in the field of infertility, presents new clinical research examining a more rapid approach to embryonic screening. The research abstract, released during the 70 th annual American Society for Reproductive Medicine (ASRM) meeting in Honolulu, Hawaii ,... [Comments]

BabyCenter Finds Mom Ready to Live the "Measured Life" in its U.S. Mobile Mom 2014 Report: Health & Fitness Go Mobile for Moms

10/22/2014
SAN FRANCISCO , Oct. 22, 2014 Moms are ready to live the "measured life" using fitness and health trackers for themselves and their kids, according to the results of the BabyCenter® U.S. Mobile Mom 2014 Report: Health & Fitness Go Mobile for Moms, the latest installment in BabyCenter's 21 st  Century Mom® Insights Series. BabyCenter, the number 1 pregnancy a... [Comments]

New, State-Of-The-Art Body Bag Minimizes The Spread Of Bacteria And Virus

10/22/2014
LA VERNE, Calif. , Oct. 22, 2014  Paper Pak Industries, a manufacturer of innovative emergency readiness products, has developed APLS ® Body Guard Bio, a disposable, highly absorbent body bag that minimizes the spread of bacteria and virus while protecting service providers and the deceased. APLS Body Guard Bio features a rugged, external nylon shell, watertight zi... [Comments]

AVACEN Medical Announces FDA Clearance of First Medical Device with Internal Game Mode

10/22/2014
SAN DIEGO , Oct. 22, 2014 AVACEN Medical announced today that its AVACEN 100 Class II medical device received 510 (k) OTC clearance by the U.S. Food and Drug Administration. This clearance allows the AVACEN 100 to be marketed over the Internet for: the temporary relief of joint pain associated with arthritis; muscle spasms; and minor strains and sprains . Logo - http://pho... [Comments]

(Date:10/22/2014)... NJ (PRWEB) October 22, 2014 ... and services – has been working with a team ... and New Haven Farms Community Farming Collaborative to provide ... ePRO solution. The study, which started in May, ... program that provides participants weekly exposure to and participation ...
(Date:10/22/2014)... (PRWEB) October 22, 2014 Grace Century, ... and healthcare projects, announces the addition of Dr. ... to its advisory team. Dr. Siddiqui will provide further ... , A graduate of University College Medical School ... degreed in medicine in 2001. With further certification as ...
(Date:10/22/2014)... 22, 2014 According to new ... Service Type (Consulting, Integration, Deployment & Support), by ... Model (Public, Private, Others (Hybrid & Community)) - ... and segments the Cloud Professional Services Market into ... of revenues. It also identifies the drivers and ...
(Date:10/22/2014)... /PRNewswire/ - iCo Therapeutics ("iCo" or "the Company") (TSX-V: ... its Oral Amphotericin B program.  The company recently ... work involving samples from HIV/AIDS patients exposed ... pre clinical studies and regulatory filings to move ... utilizing approximately $700,000 of funding and technological advice ...
Breaking Biology Technology:myPROpad™ Topic of Panel Discussion at the Yale Food Systems Symposium 2myPROpad™ Topic of Panel Discussion at the Yale Food Systems Symposium 3Dr. Yousef Siddiqui joins the Grace Century Advisory Team 2Cloud Professional Services Market by Public, Private, Hybrid & Community Expected to Reach $34.41 Billion by 2019 - New Report by MarketsandMarkets 2Cloud Professional Services Market by Public, Private, Hybrid & Community Expected to Reach $34.41 Billion by 2019 - New Report by MarketsandMarkets 3Cloud Professional Services Market by Public, Private, Hybrid & Community Expected to Reach $34.41 Billion by 2019 - New Report by MarketsandMarkets 4Cloud Professional Services Market by Public, Private, Hybrid & Community Expected to Reach $34.41 Billion by 2019 - New Report by MarketsandMarkets 5iCo Therapeutics Announces Advancement of Oral Amphotericin B Program 2iCo Therapeutics Announces Advancement of Oral Amphotericin B Program 3
... Aoxing Pharmaceutical,Company, Inc. (OTC Bulletin Board: CAXG), which ... highly regulated narcotic,medicines and pain medication in China, ... fiscal 2008 ended September 30, 2007. China ... first quarter of fiscal 2008, a 33% sequential ...
... Convergence and New Opportunities, NEW BRUNSWICK, N.J., Nov. ... organizational changes to sharpen its,focus on opportunities outside its ... health care. These include the creation of a new,strategy ... The,changes are designed to accelerate growth for Johnson & ...
... 14 Advanced Life Sciences,Holdings, Inc. (Nasdaq: ... development and commercialization of novel drugs in the,therapeutic ... its financial results for the third quarter ended ... The net loss for the three months ended ...
Cached Biology Technology:China Aoxing Pharmaceutical Reports Financial Results for the First Quarter of Fiscal 2008 2China Aoxing Pharmaceutical Reports Financial Results for the First Quarter of Fiscal 2008 3China Aoxing Pharmaceutical Reports Financial Results for the First Quarter of Fiscal 2008 4China Aoxing Pharmaceutical Reports Financial Results for the First Quarter of Fiscal 2008 5Johnson & Johnson Announces Changes to Accelerate Growth 2Johnson & Johnson Announces Changes to Accelerate Growth 3Advanced Life Sciences Announces Third Quarter 2007 Financial Results 2Advanced Life Sciences Announces Third Quarter 2007 Financial Results 3Advanced Life Sciences Announces Third Quarter 2007 Financial Results 4Advanced Life Sciences Announces Third Quarter 2007 Financial Results 5Advanced Life Sciences Announces Third Quarter 2007 Financial Results 6Advanced Life Sciences Announces Third Quarter 2007 Financial Results 7Advanced Life Sciences Announces Third Quarter 2007 Financial Results 8Advanced Life Sciences Announces Third Quarter 2007 Financial Results 9
(Date:10/22/2014)... YORK , Oct. 22, 2014 Sanomedics ... August 2014 report by Global Research & Data Services, ... per year from 2014 through 2018, as demand for ... States is the world,s largest market for ... with advanced thermometers is Sanomedics International Holdings, Inc. ...
(Date:10/22/2014)... 22, 2014  AcelRx Pharmaceuticals, Inc. (NASDAQ: ... the  IAP310 study have been published in ... peer-reviewed journal with broad, multidisciplinary readership. IAP310 was ... safety and efficacy of Zalviso, also referred to ... the treatment of post-operative pain in patients following ...
(Date:10/20/2014)... Calif. , Oct. 20, 2014  PneumRx, Inc. ... interventional pulmonology, today announced completion of enrollment in their ... RENEW Clinical Study is the FDA-approved IDE pivotal trial ... severe emphysema. It was anticipated that the ... February 2013, would take until the end of 2014 ...
Breaking Medicine Technology:Sanomedics International Holdings Analyst Report: Taking Some Heat by BrokerBank Securities, Inc. 2AcelRx Announces Publication of Zalviso Phase 3 Abdominal Trial Results 2PneumRx Completes RENEW Pivotal Trial Enrollment 2PneumRx Completes RENEW Pivotal Trial Enrollment 3
... Data Expected in the Third Quarter --, SAN ... ), a biotechnology company focused on the development of,compounds ... has completed the last patient visit in its carotid ... analyzed to determine,VIA-2291,s effect on inflammation, and the company ...
... TOKYO, July 10 Sosei Group Corporation,("Sosei"; TSE ... completion of a Japanese Phase III clinical trial ... acquired the,exclusive distribution rights to the product in ... was designed to evaluate the safety and prevented,pregnancy ...
Cached Medicine Technology:VIA Pharmaceuticals Completes Patient Visits in Phase 2 Carotid Endarterectomy (CEA) Trial 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Carotid Endarterectomy (CEA) Trial 3VIA Pharmaceuticals Completes Patient Visits in Phase 2 Carotid Endarterectomy (CEA) Trial 4VIA Pharmaceuticals Completes Patient Visits in Phase 2 Carotid Endarterectomy (CEA) Trial 5Sosei Announces Completion of Phase III Trial for NorLevo(R) 2